Reaz Ahmmed, Md. Bayazid Hossen, Alvira Ajadee, Sabkat Mahmud et al.
Type 2 diabetes (T2D) and Clear-cell renal cell carcinoma (ccRCC) are both complicated diseases which incidence rates gradually increasing. Population based studies show that severity of ccRCC might be associated with T2D. However, so far, no researcher yet investigated about the molecular mechanism...
Alvira Ajadee, Sabkat Mahmud, Arnob Sarkar, Tooba Noor et al.
Type 2 diabetes (T2D) is a crucial risk factor for both pancreatic cancer (PC) and kidney cancer (KC). However, effective common drugs for treating PC and/or KC patients who are also suffering from T2D are currently lacking, despite the probability of their co-occurrence. Taking disease-specific mul...
Alvira Ajadee, Sabkat Mahmud, Md. Ahad Ali, Mohammad Manir Hossain Mollah et al.
Monkeypox (Mpox) is a major global human health threat after COVID-19. Its treatment becomes complicated with type-2 diabetes (T2D). It may happen due to the influence of both disease-causing common host key genes (cHKGs). Therefore, it is necessary to explore both disease-causing cHKGs to reveal th...
Sabkat Mahmud, Alvira Ajadee, Md. Bayazid Hossen, Md. Saiful Islam et al.
The most frequent endocrine cancer of the head and neck is thyroid carcinoma (THCA). Although there is increasing evidence linking THCA to genetic alterations, the exact molecular mechanism behind this relationship is not yet completely known to the researchers. There is still much to learn about TH...
Md. Al Amin Pappu, Md. Alamin, Most. Humaira Sultana, AKM Azad et al.
Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder, characterized by progressive motor and cognitive decline, leading to long-term disability and significantly impacting quality of life. While PD research has traditionally focused on dopaminergic neurons in the substant...
Alvira Ajadee, Sabkat Mahmud, Md Bayazid Hossain, Reaz Ahmmed et al.
Clear cell renal cell carcinoma (ccRCC) is the most prevalent subtype of kidney cancer. Although there is increasing evidence linking ccRCC to genetic alterations, the exact molecular mechanism behind this relationship is not yet completely known to the researchers. Though drug therapies are the bes...
Sabkat Mahmud, Alvira Ajadee, Arnob Sarker, Reaz Ahmmed et al.
Type 2 diabetes (T2D) is a crucial risk factor for both colorectal cancer (CRC) and hepatocellular carcinoma (HCC). However, so far, there was no study that has investigated common drugs against HCC and CRC during their co-occurrence with T2D patients. Consequently, patients often require multiple d...
Reaz Ahmmed, Umme Samia Antu, Tooba Noor, Md.Fahim Faysal et al.
Type-2 diabetes (T2D) is a risk factor for colorectal cancer (CRC) and the incidence rate of CRC in T2D patients is significantly higher than in control patients. It may be associated with the overlapping dysregulated genetic factors. The management of CRC becomes complicated with T2D compare to wit...
Arnob Sarker, Burhan Uddin, Reaz Ahmmed, Sabkat Mahmud et al.
Glioblastoma (GBM) is one of the most aggressive cancers due to its high mortality rate in spite of intensive treatment. It may be happened because of drug resistance against their typical receptors, since these receptor genes are often mutated by environmental stress. So identifying mutated oncodri...